Tg Therapeutics (TGTX) EBIT Margin (2017 - 2026)
Tg Therapeutics (TGTX) posted quarterly EBIT Margin of 16.98% for Q1 2026, up 985.0% year-over-year from 1.56% in Q1 2025, and down 35.24% quarter-over-quarter from 26.22% in Q4 2025.
Tg Therapeutics (TGTX) EBIT Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' EBIT Margin history runs 10 years deep, the most recent figure standing at 16.98% for Q1 2026.
- In Q1 2026, EBIT Margin rose 985.0% year-over-year to 16.98%; the TTM figure through Mar 2026 stood at 21.35% (up 586.0% YoY), while the FY2025 annual figure was 20.01%, up 727.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 16.98%, down from 26.22% in the prior quarter.
- The five-year high for EBIT Margin was 69.22% in Q3 2023, with the low at 96923.75% in Q4 2022.
- The 5-year median for EBIT Margin is 7.13% (2025), against an average of 8504.08%.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin sank 9291914 bps in 2022, then surged 9689536 bps in 2023.
- Tg Therapeutics' EBIT Margin stood at 96923.75% in 2022, then soared by 100 bps to 28.39% in 2023, then jumped by 197 bps to 27.68% in 2024, then declined by 5 bps to 26.22% in 2025, then tumbled by 35 bps to 16.98% in 2026.
- Business Quant data shows TGTX's EBIT Margin at 16.98% in Q1 2026, 26.22% in Q4 2025, and 18.16% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 9.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.02% |
| Mar 31, 2026 | 16.98% |
| Dec 31, 2025 | 26.22% |
| Sep 30, 2025 | 18.16% |
| Jun 30, 2025 | 24.69% |
| Mar 31, 2025 | 7.13% |
| Dec 31, 2024 | 27.68% |
| Sep 30, 2024 | 14.82% |
| Jun 30, 2024 | 12.00% |
| Mar 31, 2024 | -14.60% |
| Dec 31, 2023 | -28.39% |
| Sep 30, 2023 | 69.22% |
| Jun 30, 2023 | -277.93% |
| Mar 31, 2023 | -474.07% |
| Dec 31, 2022 | -96,923.75% |
| Sep 30, 2022 | -37,194.68% |
| Jun 30, 2022 | -6,555.72% |
| Mar 31, 2022 | -3,317.06% |
| Dec 31, 2021 | -4,004.61% |
| Sep 30, 2021 | -4,193.50% |